help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dohán, O.
Right arrow Articles by Carrasco, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dohán, O.
Right arrow Articles by Carrasco, N.
Endocrine Reviews 24 (1): 48-77
Copyright © 2003 by The Endocrine Society

The Sodium/Iodide Symporter (NIS): Characterization, Regulation, and Medical Significance

Orsolya Dohán, Antonio De la Vieja, Viktoriya Paroder, Claudia Riedel, Mona Artani, Mia Reed, Christopher S. Ginter and Nancy Carrasco

Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461

Correspondence: Address all correspondence and requests for reprints to: Nancy Carrasco, M.D., Department of Molecular Pharmacology, Albert Einstein College of Medicine, Forchheimer Building, Room 209, 1300 Morris Park Avenue, Bronx, New York 10461. E-mail: carrasco{at}aecom.yu.edu

The Na+/I– symporter (NIS) is an integral plasma membrane glycoprotein that mediates active I– transport into the thyroid follicular cells, the first step in thyroid hormone biosynthesis. NIS-mediated thyroidal I– transport from the bloodstream to the colloid is a vectorial process made possible by the selective targeting of NIS to the basolateral membrane. NIS also mediates active I– transport in other tissues, including salivary glands, gastric mucosa, and lactating mammary gland, in which it translocates I– into the milk for thyroid hormone biosynthesis by the nursing newborn. NIS provides the basis for the effective diagnostic and therapeutic management of thyroid cancer and its metastases with radioiodide. NIS research has proceeded at an astounding pace after the 1996 isolation of the rat NIS cDNA, comprising the elucidation of NIS secondary structure and topology, biogenesis and posttranslational modifications, transcriptional and posttranscriptional regulation, electrophysiological analysis, isolation of the human NIS cDNA, and determination of the human NIS genomic organization. Clinically related topics include the analysis of congenital I– transport defect-causing NIS mutations and the role of NIS in thyroid cancer. NIS has been transduced into various kinds of cancer cells to render them susceptible to destruction with radioiodide. Most dramatically, the discovery of endogenous NIS expression in more than 80% of human breast cancer samples has raised the possibility that radioiodide may be a valuable novel tool in breast cancer diagnosis and treatment.




This article has been cited by other articles:


Home page
 ScienceHome page
S. Faham, A. Watanabe, G. M. Besserer, D. Cascio, A. Specht, B. A. Hirayama, E. M. Wright, and J. Abramson
The Crystal Structure of a Sodium Galactose Transporter Reveals Mechanistic Insights into Na+/Sugar Symport
Science, August 8, 2008; 321(5890): 810 - 814.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
C. Romei, R. Ciampi, P. Faviana, L. Agate, E. Molinaro, V. Bottici, F. Basolo, P. Miccoli, F. Pacini, A. Pinchera, et al.
BRAFV600E mutation, but not RET/PTC rearrangements, is correlated with a lower expression of both thyroperoxidase and sodium iodide symporter genes in papillary thyroid cancer
Endocr. Relat. Cancer, June 1, 2008; 15(2): 511 - 520.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. D. Reed-Tsur, A. De la Vieja, C. S. Ginter, and N. Carrasco
Molecular Characterization of V59E NIS, a Na+/I- Symporter Mutant that Causes Congenital I- Transport Defect
Endocrinology, June 1, 2008; 149(6): 3077 - 3084.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
M. Dayem, C. Basquin, V. Navarro, P. Carrier, R. Marsault, P. Chang, S. Huc, E. Darrouzet, S. Lindenthal, and T. Pourcher
Comparison of expressed human and mouse sodium/iodide symporters reveals differences in transport properties and subcellular localization
J. Endocrinol., April 1, 2008; 197(1): 95 - 109.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
O. Dohan, C. Portulano, C. Basquin, A. Reyna-Neyra, L. M. Amzel, and N. Carrasco
The Na+/I symporter (NIS) mediates electroneutral active transport of the environmental pollutant perchlorate
PNAS, December 18, 2007; 104(51): 20250 - 20255.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
G. Riesco-Eizaguirre and P. Santisteban
New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy
Endocr. Relat. Cancer, December 1, 2007; 14(4): 957 - 977.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. J. Willhauck, B.-R. Sharif Samani, F.-J. Gildehaus, I. Wolf, R. Senekowitsch-Schmidtke, H.-J. Stark, B. Goke, J. C. Morris, and C. Spitzweg
Application of 188Rhenium as an Alternative Radionuclide for Treatment of Prostate Cancer after Tumor-Specific Sodium Iodide Symporter Gene Expression
J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4451 - 4458.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
W. J. G. Oyen, L. Bodei, F. Giammarile, H. R. Maecke, J. Tennvall, M. Luster, and B. Brans
Targeted therapy in nuclear medicine current status and future prospects
Ann. Onc., November 1, 2007; 18(11): 1782 - 1792.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
M. A. Walter, C. P. Turtschi, C. Schindler, P. Minnig, J. Muller-Brand, and B. Muller
The Dental Safety Profile of High-Dose Radioiodine Therapy for Thyroid Cancer: Long-Term Results of a Longitudinal Cohort Study
J. Nucl. Med., October 1, 2007; 48(10): 1620 - 1625.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. De la Vieja, M. D. Reed, C. S. Ginter, and N. Carrasco
Amino Acid Residues in Transmembrane Segment IX of the Na+/I Symporter Play a Role in Its Na+ Dependence and Are Critical for Transport Activity
J. Biol. Chem., August 31, 2007; 282(35): 25290 - 25298.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. M. Norden, F. Larsson, S. Tedelind, T. Carlsson, C. Lundh, E. Forssell-Aronsson, and M. Nilsson
Down-regulation of the Sodium/Iodide Symporter Explains 131I-Induced Thyroid Stunning
Cancer Res., August 1, 2007; 67(15): 7512 - 7517.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Durante, E. Puxeddu, E. Ferretti, R. Morisi, S. Moretti, R. Bruno, F. Barbi, N. Avenia, A. Scipioni, A. Verrienti, et al.
BRAF Mutations in Papillary Thyroid Carcinomas Inhibit Genes Involved in Iodine Metabolism
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2840 - 2843.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
E. D. McLanahan, J. L. Campbell Jr, D. C. Ferguson, B. Harmon, J. M. Hedge, K. M. Crofton, D. R. Mattie, L. Braverman, D. A. Keys, M. Mumtaz, et al.
Low-Dose Effects of Ammonium Perchlorate on the Hypothalamic-Pituitary-Thyroid Axis of Adult Male Rats Pretreated with PCB126
Toxicol. Sci., June 1, 2007; 97(2): 308 - 317.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Krause, S. Karger, A. Schierhorn, S. Poncin, M.-C. Many, and D. Fuhrer
Proteomic Profiling of Cold Thyroid Nodules
Endocrinology, April 1, 2007; 148(4): 1754 - 1763.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
K. Krause, S. Karger, O. Gimm, S.-Y. Sheu, H. Dralle, A. Tannapfel, K. W. Schmid, C. Dupuy, and D. Fuhrer
Characterisation of DEHAL1 expression in thyroid pathologies
Eur. J. Endocrinol., March 1, 2007; 156(3): 295 - 301.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
M. Milenkovic, X. De Deken, L. Jin, M. De Felice, R. Di Lauro, J. E Dumont, B. Corvilain, and F. Miot
Duox expression and related H2O2 measurement in mouse thyroid: onset in embryonic development and regulation by TSH in adult
J. Endocrinol., March 1, 2007; 192(3): 615 - 626.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
K. J. Rhoden, S. Cianchetta, V. Stivani, C. Portulano, L. J. V. Galietta, and G. Romeo
Cell-based imaging of sodium iodide symporter activity with the yellow fluorescent protein variant YFP-H148Q/I152L
Am J Physiol Cell Physiol, February 1, 2007; 292(2): C814 - C823.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. Szinnai, L. Lacroix, A. Carre, F. Guimiot, M. Talbot, J. Martinovic, A.-L. Delezoide, M. Vekemans, S. Michiels, B. Caillou, et al.
Sodium/Iodide Symporter (NIS) Gene Expression Is the Limiting Step for the Onset of Thyroid Function in the Human Fetus
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 70 - 76.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
G. Riesco-Eizaguirre and P. Santisteban
A perspective view of sodium iodide symporter research and its clinical implications.
Eur. J. Endocrinol., October 1, 2006; 155(4): 495 - 512.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
T Kogai, K Taki, and G A Brent
Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.
Endocr. Relat. Cancer, September 1, 2006; 13(3): 797 - 826.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Shrivastava, M. Tiwari, R. A. Sinha, A. Kumar, A. K. Balapure, V. K. Bajpai, R. Sharma, K. Mitra, A. Tandon, and M. M. Godbole
Molecular Iodine Induces Caspase-independent Apoptosis in Human Breast Carcinoma Cells Involving the Mitochondria-mediated Pathway
J. Biol. Chem., July 14, 2006; 281(28): 19762 - 19771.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
R. Opitz, A. Trubiroha, C. Lorenz, I. Lutz, S. Hartmann, T. Blank, T. Braunbeck, and W. Kloas
Expression of sodium-iodide symporter mRNA in the thyroid gland of Xenopus laevis tadpoles: developmental expression, effects of antithyroidal compounds, and regulation by TSH.
J. Endocrinol., July 1, 2006; 190(1): 157 - 170.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. L. Velez, E. Costamagna, E. T. Kimura, L. Fozzatti, C. G. Pellizas, M. M. Montesinos, A. M. Lucero, A. H. Coleoni, P. Santisteban, and A. M. Masini-Repiso
Bacterial Lipopolysaccharide Stimulates the Thyrotropin-Dependent Thyroglobulin Gene Expression at the Transcriptional Level by Involving the Transcription Factors Thyroid Transcription Factor-1 and Paired Box Domain Transcription Factor 8
Endocrinology, July 1, 2006; 147(7): 3260 - 3275.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
V. Paroder, S. R. Spencer, M. Paroder, D. Arango, S. Schwartz Jr., J. M. Mariadason, L. H. Augenlicht, S. Eskandari, and N. Carrasco
Na+/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: Molecular characterization of SMCT
PNAS, May 9, 2006; 103(19): 7270 - 7275.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
O. Dohan, A. De la Vieja, and N. Carrasco
Hydrocortisone and Purinergic Signaling Stimulate Sodium/Iodide Symporter (NIS)-Mediated Iodide Transport in Breast Cancer Cells
Mol. Endocrinol., May 1, 2006; 20(5): 1121 - 1137.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. Szinnai, S. Kosugi, C. Derrien, N. Lucidarme, V. David, P. Czernichow, and M. Polak
Extending the Clinical Heterogeneity of Iodide Transport Defect (ITD): A Novel Mutation R124H of the Sodium/Iodide Symporter Gene and Review of Genotype-Phenotype Correlations in ITD
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1199 - 1204.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. Saez, M. A. Martinez-Brocca, C. Castilla, A. Soto, E. Navarro, M. Tortolero, J. A. Pintor-Toro, and M. A. Japon
Prognostic Significance of Human Pituitary Tumor-Transforming Gene Immunohistochemical Expression in Differentiated Thyroid Cancer
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1404 - 1409.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. Bernier-Valentin, S. Trouttet-Masson, R. Rabilloud, S. Selmi-Ruby, and B. Rousset
Three-Dimensional Organization of Thyroid Cells into Follicle Structures Is a Pivotal Factor in the Control of Sodium/Iodide Symporter Expression
Endocrinology, April 1, 2006; 147(4): 2035 - 2042.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
G Riesco-Eizaguirre, P Gutierrez-Martinez, M A Garcia-Cabezas, M Nistal, and P Santisteban
The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I- targeting to the membrane.
Endocr. Relat. Cancer, March 1, 2006; 13(1): 257 - 269.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
M. Josefsson, L. Evilevitch, B. Westrom, T. Grunditz, and E. Ekblad
Sodium-iodide symporter mediates iodide secretion in rat gastric mucosa in vitro.
Experimental Biology and Medicine, March 1, 2006; 231(3): 277 - 281.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
D. D. Vadysirisack, D. H. Shen, and S. M. Jhiang
Correlation of Na+/I- Symporter Expression and Activity: Implications of Na+/I- Symporter as an Imaging Reporter Gene
J. Nucl. Med., January 1, 2006; 47(1): 182 - 190.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. De la Vieja, C. S. Ginter, and N. Carrasco
Molecular Analysis of a Congenital Iodide Transport Defect: G543E Impairs Maturation and Trafficking of the Na+/I- Symporter
Mol. Endocrinol., November 1, 2005; 19(11): 2847 - 2858.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Cengic, C. H. Baker, M. Schutz, B. Goke, J. C. Morris, and C. Spitzweg
A Novel Therapeutic Strategy for Medullary Thyroid Cancer Based on Radioiodine Therapy following Tissue-Specific Sodium Iodide Symporter Gene Expression
J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4457 - 4464.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. Kimura, S.-C. Tzou, R. Rocchi, M. Kimura, K. Suzuki, A. F. Parlow, N. R. Rose, and P. Caturegli
Interleukin (IL)-12-Driven Primary Hypothyroidism: the Contrasting Roles of Two Th1 Cytokines (IL-12 and Interferon-{gamma})
Endocrinology, August 1, 2005; 146(8): 3642 - 3651.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
K. Krohn, D. Fuhrer, Y. Bayer, M. Eszlinger, V. Brauer, S. Neumann, and R. Paschke
Molecular Pathogenesis of Euthyroid and Toxic Multinodular Goiter
Endocr. Rev., June 1, 2005; 26(4): 504 - 524.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
V. Porra, C. Ferraro-Peyret, C. Durand, S. Selmi-Ruby, H. Giroud, N. Berger-Dutrieux, M. Decaussin, J.-L. Peix, C. Bournaud, J. Orgiazzi, et al.
Silencing of the Tumor Suppressor Gene SLC5A8 Is Associated with BRAF Mutations in Classical Papillary Thyroid Carcinomas
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 3028 - 3035.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Radiol.Home page
A F Leger, M Pellan, F Dagousset, A Chevalier, I Keller, and J Clerc
A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for sequential treatments
Br. J. Radiol., May 1, 2005; 78(929): 428 - 432.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Arturi, E. Ferretti, I. Presta, T. Mattei, A. Scipioni, D. Scarpelli, R. Bruno, L. Lacroix, E. Tosi, A. Gulino, et al.
Regulation of Iodide Uptake and Sodium/Iodide Symporter Expression in the MCF-7 Human Breast Cancer Cell Line
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2321 - 2326.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
A. C F Ferreira, L. P Lima, R. L Araujo, G. Muller, R. P Rocha, D. Rosenthal, and D. P Carvalho
Rapid regulation of thyroid sodium-iodide symporter activity by thyrotrophin and iodine
J. Endocrinol., January 1, 2005; 184(1): 69 - 76.
[Abstract] [Full Text] [PDF]

Home page
 J. Physiol.Home page
M. A Fragoso, V. Fernandez, R. Forteza, S. H Randell, M. Salathe, and G. E Conner
Transcellular thiocyanate transport by human airway epithelia
J. Physiol., November 15, 2004; 561(1): 183 - 194.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
F. Furuya, H. Shimura, A. Miyazaki, K. Taki, K. Ohta, K. Haraguchi, T. Onaya, T. Endo, and T. Kobayashi
Adenovirus-Mediated Transfer of Thyroid Transcription Factor-1 Induces Radioiodide Organification and Retention in Thyroid Cancer Cells
Endocrinology, November 1, 2004; 145(11): 5397 - 5405.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. Mitrofanova, R. Unfer, N. Vahanian, W. Daniels, E. Roberson, T. Seregina, P. Seth, and C. Link Jr.
Rat Sodium Iodide Symporter for Radioiodide Therapy of Cancer
Clin. Cancer Res., October 15, 2004; 10(20): 6969 - 6976.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. Dentice, C. Luongo, A. Elefante, R. Romino, R. Ambrosio, M. Vitale, G. Rossi, G. Fenzi, and D. Salvatore
Transcription Factor Nkx-2.5 Induces Sodium/Iodide Symporter Gene Expression and Participates in Retinoic Acid- and Lactation-Induced Transcription in Mammary Cells
Mol. Cell. Biol., September 15, 2004; 24(18): 7863 - 7877.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
I. L. Wapnir, M. Goris, A. Yudd, O. Dohan, D. Adelman, K. Nowels, and N. Carrasco
The Na+/I- Symporter Mediates Iodide Uptake in Breast Cancer Metastases and Can Be Selectively Down-Regulated in the Thyroid
Clin. Cancer Res., July 1, 2004; 10(13): 4294 - 4302.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
X. Lin, A. H. Fischer, K.-y. Ryu, J.-y. Cho, T. J. Sferra, R. T. Kloos, E. L. Mazzaferri, and S. M. Jhiang
Application of the Cre/loxP System to Enhance Thyroid-Targeted Expression of Sodium/Iodide Symporter
J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2344 - 2350.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
L. S. Zuckier, O. Dohan, Y. Li, C. J. Chang, N. Carrasco, and E. Dadachova
Kinetics of Perrhenate Uptake and Comparative Biodistribution of Perrhenate, Pertechnetate, and Iodide by NaI Symporter-Expressing Tissues In Vivo
J. Nucl. Med., March 1, 2004; 45(3): 500 - 507.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
C. Puppin, F. Arturi, E. Ferretti, D. Russo, R. Sacco, G. Tell, G. Damante, and S. Filetti
Transcriptional Regulation of Human Sodium/Iodide Symporter Gene: A Role for Redox Factor-1
Endocrinology, March 1, 2004; 145(3): 1290 - 1293.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
A. De la Vieja, C. S. Ginter, and N. Carrasco
The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number
J. Cell Sci., February 15, 2004; 117(5): 677 - 687.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Interv.Home page
S. M. Ferguson and R. D. Blakely
The Choline Transporter Resurfaces: New Roles for Synaptic Vesicles?
Mol. Interv., February 1, 2004; 4(1): 22 - 37.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Costamagna, B. Garcia, and P. Santisteban
The Functional Interaction between the Paired Domain Transcription Factor Pax8 and Smad3 Is Involved in Transforming Growth Factor-{beta} Repression of the Sodium/Iodide Symporter Gene
J. Biol. Chem., January 30, 2004; 279(5): 3439 - 3446.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Kogai, Y. Kanamoto, L. H. Che, K. Taki, F. Moatamed, J. J. Schultz, and G. A. Brent
Systemic Retinoic Acid Treatment Induces Sodium/Iodide Symporter Expression and Radioiodide Uptake in Mouse Breast Cancer Models
Cancer Res., January 1, 2004; 64(1): 415 - 422.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society